evidence: By — Lauran Neergaard, Associated Press Lauran Neergaard, Associated Press By — Matthew Perrone, Associated Press Matthew Perrone, Associated Press Leave your feedback Share Copy URL https://www.pbs.org/newshour/health/fda-panel-backs-pfizers-low-dose-covid-19-vaccine-for-kids Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kids Health Oct 26, 2021 5:17 PM EDT WASHINGTON (AP) — The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as a panel of government advisers on Tuesday endorsed kid-size doses of Pfizer’s shots for 5- to 11-year-olds. A Food and Drug Administration advisory panel voted unanimously, with one abstention, that the vaccine’s benefits in preventing COVID-19 in that age group outweigh any potential risks — including a heart-related side effect that’s been very rare in teens and young adults despite their use of a much higher shot dose.